About AST

Transplant News

June, 2013

June 07, 2013
Blood tests OK for fibrosis diagnosis in hepatitus C MedPage Today Blood testing can accurately identify clinically significant fibrosis and cirrhosis in people with hepatitis C virus (HCV) infection and may be an alternative to liver biopsy in some patients, a new study found. The analysis of 172 studies comparing various blood tests to biopsy in HCV patients revealed that some of the simplest, cheapest blood tests performed as well as more expensive, complex tests, reported Dr. Roger Chou, and Ngoc Wasson, MPH, from the Evidence-Based Practice Center at Oregon Health and Science... Read More...
June 06, 2013
The AST and ASTS have released a joint statement regarding the recent media attention to the OPTN lung allocation policy. Read the statement here.
June 05, 2013
Senior Achievement Award in Clinical Transplantation Russell Wiesner, MD The Senior Achievement Award in Clinical Transplantation recognizes outstanding contributions to clinical transplantation over the course of a clinical career. Dr. Wiesner is a leader in hepatology and liver transplantation. He was a major force in the development and implementation of the meld-based organ allocation system for livers. He has contributed to more than 270 peer-reviewed publications while playing an active role in AST and UNOS. Mentoring Award Rita Alloway, PharmD The AST Mentoring Award is intended to... Read More...
June 05, 2013
AST/Novartis Basic Science Faculty Development Grant Dr. Jamil Azzi Research Title: The Novel Role of P13Ky Pathway in Alloimmunity and Tolerance Dr. Azzi is an instructor in medicine from Brigham and Women’s Hospital. He is particularly interested in achieving allograft tolerance, and developed an early interest in exploring innovative and safer immunosuppressive strategies. His previous research experiences lead him to conclude that finding tolerogenic strategies relies on targeting key players in the survival of memory and regulatory cells. Dr. Azzi’s goal is to improve patient care as an... Read More...

May, 2013

May 31, 2013
Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies NCBI In the United States, more than 2600 kidneys are discarded annually, from the total number of kidneys procured for transplant. It has been hypothesized that this organ pool may be used as a platform for renal bioengineering and regeneration research. The purpose of the current study was to test if the same strategy can be applied to discarded human kidneys in order to obtain human renal ECM scaffolds. The results show that the sodium dodecylsulfate-based decellularization protocol completely... Read More...
May 31, 2013
We're pleased to now offer AST-branded apparel, exclusively from the AST Store! Pick up one of our new fleece jackets, polo shirts or baseball caps, embroidered with the AST logo. Items start at just $20!  
May 31, 2013
Are you interested in receiving recognition and increased exposure for your transplant center? Does you center support the future of transplantation and value the educational, networking and research opportunities that the American Society of Transplantation (AST) provides to its members? Does your center support AST's lobbying of the U.S. Congress and Federal Agencies to secure a more transplant provided friendly environment for patients and physicians? If the answer to these questions is YES, please consider having your center participate in AST's Institutional Support Program. With a... Read More...
May 28, 2013
Effective May 20, 2013, Robert W. Walsh has been appointed as the Director of HRSA's Division of Transplantation (DoT). Bob has worked within the DoT for approximately five years, most recently as the Project Officer for the Organ Procurement and Transplantation Network (OPTN) contract. In that capacity, he also served as an ex offivio member of the OPTN Board of Directors and numerous committees. Prior to joining HRSA, Bob worked at the American Psychological Association in Washington, DC. There, he served in several capacities including the Associate Executive Director for Governance. Bob... Read More...
May 24, 2013
4 key issues in facial allotransplantation By Maria Frisch Facial allotransplantation has transformed the future of patients with severe facial disfigurement by allowing for nearly normal facial restoration. Since 2005, at least 21 facial allotransplantations have been performed worldwide, with an estimated 90 percent overall success rate — two of the 21 patients died. This article summarizes four key issues regarding this procedure. Read more.  Liver... Read More...
May 24, 2013
The AST is only as strong as our members, so we are asking for your help in supporting the AST Endowment if you have not already done so this year. The Endowment Fund has made it possible for the society to subsidize programs that are core to our mission, such as funding for research grants and education for the next generation of transplant professionals at our annual fellows symposium. In a time when funding from external sources is declining, any contribution, great or small, is very much appreciated. And you can be confident that 100... Read More...

Pages